ClearOne enters merger deal to acquire Vivani unit Cortigent
PUBT · 2d ago
Share
Listen to the news
- ClearOne agreed to merge with Vivani Medical’s unit Cortigent, which will become a wholly owned subsidiary at closing.
- Vivani will receive 12,500,000 ClearOne shares; expected ownership in the combined company is 59.4% to 67.5%.
- ClearOne shareholders are expected to own 12.7% to 14.4% following the deal, depending on financing.
- ClearOne plans a concurrent Form S-1 equity raise of $10 million to $15 million tied to closing.
- ClearOne is expected to be renamed Cortigent Holdings and trade on Nasdaq under ticker CRGT; closing targeted for Q3 2026.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. ClearOne Inc. published the original content used to generate this news brief via Business Wire (Ref. ID: 20260702293602) on July 02, 2026, and is solely responsible for the information contained therein.
Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.
What's Trending
No content on the Webull website shall be considered a recommendation or solicitation for the purchase or sale of securities, options or other investment products. All information and data on the website is for reference only and no historical data shall be considered as the basis for judging future trends.
Copyright © 2026 Webull. All Rights Reserved